M&A
confidence high
sentiment positive
materiality 0.75
Phibro completes $350M acquisition of Zoetis' medicated feed additive portfolio
PHIBRO ANIMAL HEALTH CORP
- Acquired >37 product lines across ~80 countries, six manufacturing sites in US, Italy, China, and >300 employees.
- Funded with $350M cash: $189M Delayed Draw Term A-1 Loans and $161M A-2 Loans under existing credit agreement.
- Expected to boost profitability, EBITDA margin, and be accretive to adjusted EPS; more details on Nov 7 Q1 call.
- Portfolio complements Phibro's vaccines, nutritional specialties, and mineral nutrition.